255 related articles for article (PubMed ID: 21086934)
1. Usefulness of thiopurine methyltransferase and thiopurine metabolite analysis in clinical practice in patients with inflammatory bowel diseases.
Dewit O
Acta Gastroenterol Belg; 2010; 73(3):331-5. PubMed ID: 21086934
[TBL] [Abstract][Full Text] [Related]
2. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
3. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease.
Kennedy NA; Asser TL; Mountifield RE; Doogue MP; Andrews JM; Bampton PA
Intern Med J; 2013 Mar; 43(3):278-86. PubMed ID: 22946880
[TBL] [Abstract][Full Text] [Related]
5. Relationship between azathioprine dosage and thiopurine metabolites in pediatric IBD patients: identification of covariables using multilevel analysis.
Nguyen TV; Vu DH; Nguyen TM; Lachaux A; Boulieu R
Ther Drug Monit; 2013 Apr; 35(2):251-7. PubMed ID: 23503453
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
7. Role of thiopurine metabolite testing and thiopurine methyltransferase determination in pediatric IBD.
Benkov K; Lu Y; Patel A; Rahhal R; Russell G; Teitelbaum J;
J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):333-40. PubMed ID: 23287804
[TBL] [Abstract][Full Text] [Related]
8. Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients.
González-Lama Y; Bermejo F; López-Sanromán A; García-Sánchez V; Esteve M; Cabriada JL; McNicholl AG; Pajares R; Casellas F; Merino O; Carpio D; Vera MI; Muñoz C; Calvo M; Benito LM; Bujanda L; García-Fernández FJ; Ricart E; Ginard D; Velasco M; Carneros JA; Manceñido N; Calvo M; Algaba A; Froilan C; Cara C; Maté J; Abreu L; Gisbert JP;
Aliment Pharmacol Ther; 2011 Sep; 34(5):544-54. PubMed ID: 21722149
[TBL] [Abstract][Full Text] [Related]
9. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
Al Hadithy AF; de Boer NK; Derijks LJ; Escher JC; Mulder CJ; Brouwers JR
Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214
[TBL] [Abstract][Full Text] [Related]
10. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
[TBL] [Abstract][Full Text] [Related]
11. High TPMT enzyme activity does not explain drug resistance due to preferential 6-methylmercaptopurine production in patients on thiopurine treatment.
van Egmond R; Chin P; Zhang M; Sies CW; Barclay ML
Aliment Pharmacol Ther; 2012 May; 35(10):1181-9. PubMed ID: 22486532
[TBL] [Abstract][Full Text] [Related]
12. The role of inosine-5'-monophosphate dehydrogenase in thiopurine metabolism in patients with inflammatory bowel disease.
Haglund S; Vikingsson S; Söderman J; Hindorf U; Grännö C; Danelius M; Coulthard S; Peterson C; Almer S
Ther Drug Monit; 2011 Apr; 33(2):200-8. PubMed ID: 21311411
[TBL] [Abstract][Full Text] [Related]
13. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease.
Kreijne JE; Seinen ML; Wilhelm AJ; Bouma G; Mulder CJ; van Bodegraven AA; de Boer NK
Ther Drug Monit; 2015 Dec; 37(6):797-804. PubMed ID: 25853923
[TBL] [Abstract][Full Text] [Related]
14. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X
Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052
[TBL] [Abstract][Full Text] [Related]
15. [Optimising azathioprine treatment: determination of thiopurine methyltransferase activity and thiopurine metabolites].
Alvarez Beltran M; Infante Pina D; Tormo Carnicé R; Segarra Cantón O; Redecillas Ferreiro S
An Pediatr (Barc); 2009 Feb; 70(2):126-31. PubMed ID: 19217567
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine metabolite ratios for monitoring therapy in pediatric Crohn disease.
Kopylov U; Amre D; Theoret Y; Deslandres C; Seidman EG
J Pediatr Gastroenterol Nutr; 2014 Oct; 59(4):511-5. PubMed ID: 24918978
[TBL] [Abstract][Full Text] [Related]
17. The role of thiopurine metabolite monitoring in inflammatory bowel disease.
Beswick L; Friedman AB; Sparrow MP
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):383-92. PubMed ID: 24684593
[TBL] [Abstract][Full Text] [Related]
18. Getting the best out of thiopurine therapy: thiopurine S-methyltransferase and beyond.
Fong SC; Blaker PA; Arenas-Hernandez M; Marinaki AM; Sanderson JD
Biomark Med; 2015; 9(1):51-65. PubMed ID: 25605455
[TBL] [Abstract][Full Text] [Related]
19. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM
Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256
[TBL] [Abstract][Full Text] [Related]
20. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B
Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
